ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹182 Cr | ₹-416 Cr | ₹-148 Cr | ₹-396 Cr | ₹-72 Cr |
What is the latest Cash Flow from Investing Activities ratio of ABBOTT INDIA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹182 Cr |
| Mar2024 | ₹-416 Cr |
| Mar2023 | ₹-148 Cr |
| Mar2022 | ₹-396 Cr |
| Mar2021 | ₹-72 Cr |
How is Cash Flow from Investing Activities of ABBOTT INDIA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹182 Cr | Positive | |
| Mar2024 | ₹-416 Cr | Negative | |
| Mar2023 | ₹-148 Cr | Negative | |
| Mar2022 | ₹-396 Cr | Negative | |
| Mar2021 | ₹-72 Cr | - | |
Compare Cash Flow from Investing Activities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹55,696.9 Cr | 1.9% | -3.6% | -17.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 1.9% |
-3.6% |
-17.9% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses